1994
Fluvoxamine Open-Label Treatment of Adolescent Inpatients with Obsessive-Compulsive Disorder or Depression
APTER A, RATZONI G, KING R, WEIZMAN A, IANCU I, BINDER M, RIDDLE M. Fluvoxamine Open-Label Treatment of Adolescent Inpatients with Obsessive-Compulsive Disorder or Depression. Journal Of The American Academy Of Child & Adolescent Psychiatry 1994, 33: 342-348. PMID: 8169178, DOI: 10.1097/00004583-199403000-00007.Peer-Reviewed Original ResearchConceptsObsessive-compulsive disorderMajor depressive disorderYale-Brown Obsessive Compulsive ScaleOvert Aggression ScaleBeck Depression InventorySide effectsSuicide Potential ScaleSpecific serotonin uptake inhibitorAdolescent inpatientsEfficacy of fluvoxamineOpen-label trialOpen-label treatmentCommon side effectsSerotonin uptake inhibitorSerious side effectsShort-term treatmentY-BOCS scoresObsessive Compulsive ScaleDaily dosesTarget symptomsDepressive disorderDemonstrated efficacyInvestigational basisUptake inhibitorFluvoxamine
1991
Sudden Death in Children Receiving Norpramin®: A Review of Three Reported Cases and Commentary
RIDDLE M, NELSON J, KLEINMAN C, RASMUSSON A, LECKMAN J, KING R, COHEN D. Sudden Death in Children Receiving Norpramin®: A Review of Three Reported Cases and Commentary. Journal Of The American Academy Of Child & Adolescent Psychiatry 1991, 30: 104-108. PMID: 2005044, DOI: 10.1097/00004583-199101000-00016.Peer-Reviewed Original Research